Report Content
Chapter 1 Methodology & Scope
1.1 Market definition
1.2 Base estimates & calculations
1.3 Forecast calculation
1.4 Covid-19 impact analysis at global level
1.5 Data validation
1.6 Data sources
1.6.1 Primary
1.6.2 Secondary
1.6.2.1 Paid sources
1.6.2.2 Public sources
Chapter 2 Executive Summary
2.1 U.S. hormone replacement therapy industry 360º synopsis, 2018 – 2032 (USD Million)
2.1.1 Business trends
Chapter 3 U.S. Hormone Replacement Therapy Market Insights
3.1 Industry landscape, 2018 – 2032 (USD Million)
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing geriatric population
3.2.1.2 Rising awareness of post-menopausal issues
3.2.1.3 Increasing development of novel drug delivery systems for hormone imbalance issues
3.2.1.4 Rising prevalence of hormonal disorders
3.2.2 Industry pitfalls & challenges
3.2.2.1 High cost associated with hormone replacement therapy
3.2.2.2 Adverse effects of hormone replacement therapy
3.3 Growth potential analysis
3.3.1 By product
3.3.2 By route of administration
3.3.3 By disease type
3.3.4 By distribution channel
3.4 COVID-19 impact analysis
3.5 Regulatory landscape
3.6 Porter’s analysis
3.7 PESTEL analysis
Chapter 4 Competitive Landscape, 2022
4.1 Introduction
4.2 Company matrix analysis, 2022
4.3 Competitive analysis of major market players, 2022
4.4 Competitive positioning matrix, 2022
4.5 Strategic dashboard, 2022
Chapter 5 U.S. Hormone Replacement Therapy Market Estimates and Forecast, By Product, 2018 - 2032 (USD Million)
5.1 Key trends, by product
5.2 Estrogen & progesterone replacement therapy
5.3 Thyroid replacement therapy
5.4 Growth hormone replacement therapy
5.5 Parathyroid hormone replacement therapy
5.6 Testosterone replacement therapy
Chapter 6 U.S. Hormone Replacement Therapy Market Estimates and Forecast, By Route of Administration, 2018 - 2032 (USD Million)
6.1 Key trends, by route of administration
6.2 Oral
6.3 Parenteral
6.4 Other routes of administration
Chapter 7 U.S. Hormone Replacement Therapy Market Estimates and Forecast, By Disease Type, 2018 - 2032 (USD Million)
7.1 Key trends, by disease type
7.2 Menopause
7.3 Growth hormone deficiency
7.4 Male hypogonadism
7.5 Hypothyroidism
7.6 Hypoparathyroidism
7.7 Other disease types
Chapter 8 U.S. Hormone Replacement Therapy Market Estimates and Forecast, By Distribution Channel, 2018 - 2032 (USD Million)
8.1 Key trends, by distribution channel
8.2 Hospital pharmacies
8.3 Retail pharmacies
8.4 Online pharmacies
Chapter 9 Company Profiles
9.1 Eli Lilly and Company
9.2 Bayer AG
9.3 Pfizer Inc.
9.4 Viatris, Inc.
9.5 Noven Pharmaceuticals, Inc.
9.6 Merck KGaA
9.7 Novo Nordisk A/S
9.8 F. Hoffmann-La Roche Ltd.
9.9 ASCEND Therapeutics US, LLC.
9.10 Abbott Laboratories
9.11 Teva Pharmaceutical Industries Ltd.
9.12 Novartis AG
